Point-of-Care Screening Expands Accessibility
The Blood Screening Market is seeing notable growth in point-of-care (POC) testing, particularly in remote or resource-limited regions. POC devices allow healthcare workers to test donor blood on-site without needing sophisticated lab infrastructure. This model is especially effective in rural areas where transportation to central labs can delay results and risk product wastage. Portable screening units, often battery-powered and highly automated, are becoming essential tools in mobile blood donation drives. MRFR projects the market’s value to rise from USD 3.40 billion in 2024 to USD 5.60 billion by 2032, at a CAGR of 10.20%. POC adoption not only enhances accessibility but also strengthens early detection of infectious markers, helping to maintain transfusion safety even in challenging conditions.